Machine learning is helping neuroscientists organize vast quantities of cells’ genetic data in the latest neurobiological cartography effort.

For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial failures, MetaOmics-10T represents a new starting point.

For decades, medical research has treated the human genome as the master blueprint for understanding disease. But a growing body of evidence suggests that what happens outside our cells, the sum total ...

Building a culture of compliance around respiratory protection no longer relies on guesswork. CleanSpace is making it ...

DUBAI – In a solid executive action that is in accordance with the UAE's National Strategy for Artificial Intelligence 2031, ...

POTOMAC, MARYLAND / ACCESS Newswire / February 9, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced the expansion of its Phase 2 CALMA trial for IGC-AD1 into ...

The widely used glycated hemoglobin (HbA1c) test - a standard diabetes test - may not accurately reflect blood glucose levels ...

Researchers are cautioning against relying solely on glycated haemoglobin, ‘HbA1c’, for diagnosing and monitoring diabetes in ...

Researchers are cautioning against relying solely on glycated haemoglobin (HbA1c) for diagnosing and monitoring diabetes in South Asia, especially India, due to the high prevalence of anaemia and ...

Adds world renowned GNA site to broaden genetic diversity and strengthen path toward 2026 data catalyst - POTOMAC, MARYLAND / ACCESS Newswire / February 9, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

When scientists sequence tumor DNA, they typically find small amounts of genetic code from bacteria, viruses and fungi – microorganisms that, if actually present in tumor tissues, could influence how ...